SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-143932
Filing Date
2018-04-30
Accepted
2018-05-01 10:18:22
Documents
6
Period of Report
2018-06-12
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d578139ddef14a.htm DEF 14A 384731
2 GRAPHIC g578139g0327071551902.jpg GRAPHIC 6226
3 GRAPHIC g578139g0429232555376.jpg GRAPHIC 16118
4 GRAPHIC g578139g0429232555485.jpg GRAPHIC 13026
5 GRAPHIC g578139g36m60.jpg GRAPHIC 5722
6 GRAPHIC g578139g42l64.jpg GRAPHIC 5122
  Complete submission text file 0001193125-18-143932.txt   445121
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 18793656
SIC: 2834 Pharmaceutical Preparations